Goralska M
Acta Physiol Pol. 1977 Jul-Aug;28(4):329-36.
The aim of this study was to determine the erythropoietic activity of the plasma of polycythaemic rats and of one of its protein fractions playing a role in erythropoiesis regulation. The erythropoietin activity and that of the erythropoiesis inhibitor varied in the examined plasma samples at definite time periods after induction of polycythaemia. It was demonstrated that the most suitable time of plasma collection for the inhibitor investigation is the period between 115 and 187 h after the first transfusion, and that in some cases separation of this factor from erythropoietin present simultaneously in the plasma is indispensable in order to reveal the inhibitory activity. The erythropoiesis inhibitor administered jointly with erythropoietin was found to exert no influence on erythropoiesis either in normal or in polycythaemic recipients of the tested plasma.
本研究的目的是确定红细胞增多症大鼠血浆及其在红细胞生成调节中起作用的一种蛋白质组分的促红细胞生成活性。在诱导红细胞增多症后的特定时间段内,所检测的血浆样本中的促红细胞生成素活性和红细胞生成抑制剂活性有所不同。结果表明,进行抑制剂研究时,采集血浆的最合适时间是首次输血后115至187小时之间,并且在某些情况下,为了揭示抑制活性,将该因子与血浆中同时存在的促红细胞生成素分离是必不可少的。发现与促红细胞生成素联合给药的红细胞生成抑制剂对正常或受试血浆的红细胞增多症受体的红细胞生成均无影响。